Japans Taisho Pharma faces claim over buyout price from Curi RMB, Oasis - Nikkei Asia
TAIPYDelisted Stock | USD 14.00 0.00 0.00% |
Slightly above 56% of Taisho Pharmaceutical's investor base is looking to short. The analysis of overall sentiment of trading Taisho Pharmaceutical Holdings pink sheet suggests that many investors are alarmed at this time. Taisho Pharmaceutical's investing sentiment can be driven by a variety of factors including economic data, Taisho Pharmaceutical's earnings reports, geopolitical events, and overall market trends.
Taisho |
Japans Taisho Pharma faces claim over buyout price from Curi RMB, Oasis Nikkei Asia
Read at news.google.com
Taisho Pharmaceutical Fundamental Analysis
We analyze Taisho Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Taisho Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Taisho Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Taisho Pharmaceutical is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Taisho Pharmaceutical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Taisho Pharmaceutical pink sheet to make a market-neutral strategy. Peer analysis of Taisho Pharmaceutical could also be used in its relative valuation, which is a method of valuing Taisho Pharmaceutical by comparing valuation metrics with similar companies.
Peers
Taisho Pharmaceutical Related Equities
SGIOF | Shionogi | 13.62 | ||||
RDY | Dr Reddys | 0.42 | ||||
HLN | Haleon Plc | 0.31 | ||||
PCRX | Pacira BioSciences, | 0.30 | ||||
CTLT | Catalent | 0.03 | ||||
VTRS | Viatris | 1.48 | ||||
HCM | HUTCHMED DRC | 1.83 | ||||
TEVA | Teva Pharma | 1.84 | ||||
EBS | Emergent Biosolutions | 2.42 | ||||
ELAN | Elanco Animal | 3.89 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Taisho Pink Sheet
If you are still planning to invest in Taisho Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taisho Pharmaceutical's history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |